Back to search

Article

Preclinical and Exploratory Clinical Studies of Novel 68Ga-labeled ᴅ-Peptide Antagonist for PET Imaging of TIGIT Expression in Cancers

2021-10-29

Abstract excerpt

<title>Abstract</title> <p>Purpose While TIGIT has been propelled under the spotlight as a next-generation target in cancer immunotherapy, anti-TIGIT therapy seems to be promising for a fraction of patients in clinical trials. Therefore, patient stratification is critical for this therapy, which could benefit from a whole-body, non-invasive and quantitative evaluation of TIGIT expression in cancers. In this stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6dcdde9-6c95-5577-810d-e0cc3bb3976e
DOI
10.21203/rs.3.rs-1022828/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preclinical and Exploratory Clinical Studies of Novel 68Ga-labeled ᴅ-Peptide Antagonist for PET Imaging of TIGIT Expression in CancersDOI 10.21203/rs.3.rs-1022828/v1
Select a neighboring publication to make it the new centre.